LEN vs XTNT · rev $34.19B vs rev $133.9M
LEN (LEN) versus Xtant Medical Holdings Inc (XTNT) — a side-by-side from cached financials, not a winner call.
LEN (LEN) common stock.
Xtant Medical Holdings Inc (XTNT) is a medical devices company listed on US.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
Latest reported XTNT revenue for 2025-12-31 was $133.9M. Net income was $5.0M. Revenue was up 14.2% from 2024-12-31 to 2025-12-31. XTNT currently screens at market cap $91.0M.
LEN currently screens at market cap $0. XTNT currently screens at market cap $91.0M.
Not investment advice. Open the LEN and XTNT stock pages for the full models.
Not investment advice.